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Abstract 
Purpose 
Pancreas stereotactic body radiotherapy (SBRT) treatment planning requires planners to make 
sequential, time consuming interactions with the treatment planning system (TPS) to reach the optimal 
dose distribution. We seek to develop a reinforcement learning (RL)-based planning bot to systematically 
address complex tradeoffs and achieve high plan quality consistently and efficiently. 
Methods 
The focus of pancreas SBRT planning is finding a balance between organs-at-risk (OAR) sparing 
and planning target volume (PTV) coverage. Planners evaluate dose distributions and make planning 
adjustments to optimize PTV coverage while adhering to OAR dose constraints. We have formulated 
such interactions between the planner and the TPS into a finite-horizon RL model. First, planning status 
features are evaluated based on human planners’ experience and defined as planning states. Second, 
planning actions are defined to represent steps that planners would commonly implement to address 
different planning needs. Finally, we have derived a “reward” system based on an objective function 
guided by physician-assigned constraints. The planning bot trained itself with 48 plans augmented from 
16 previously treated patients and generated plans for 24 cases in a separate validation set. 
Results 
All 24 bot-generated plans achieve similar PTV coverages compared to clinical plans while 
satisfying all clinical planning constraints. Moreover, the knowledge learned by the bot can be visualized 
and interpreted as consistent with human planning knowledge, and the knowledge maps learned in 
separate training sessions are consistent, indicating reproducibility of the learning process. 
Conclusion  
We have developed a planning bot that generates high quality treatment plans for pancreas SBRT. 
We have demonstrated that the training phase of the bot is tractable and reproducible, and the knowledge 
acquired is interpretable. As a result, the RL planning bot can potentially be incorporated into the clinical 
workflow and reduce planning inefficiencies.   
1. Introduction 
For locally advanced pancreatic cancer patients, one standard of care is concurrent chemotherapy 
with conventionally fractionated radiation therapy. Due to improvements in motion management, imaging 
technology, and treatment delivery accuracy, it is now possible to utilize stereotactic body radiotherapy 
(SBRT) for pancreatic cancer treatment with low risks of radiation-induced toxicity 1. With SBRT, 
radiation dose is delivered to patients over shorter periods and without significant delays in systemic 
therapy 2. National database studies have suggested that chemotherapy followed by SBRT results in better 
outcomes than chemotherapy alone or chemotherapy concurrent with conventionally-fractionated 
intensity-modulated radiotherapy (IMRT) 3,4. However, the treatment planning of pancreas SBRT poses a 
challenge to planners given pancreas SBRT treatments are inherently difficult to plan, considering 
patient-specific planning target volume (PTV) coverage and organs-at-risk (OAR) sparing tradeoff 
requirements and high inter-patient anatomy variability.  
Treatment planning, especially pancreas SBRT planning, is inherently iterative and interactive. 
The planning process starts with a planner setting initial optimization constraints to the PTV and OARs 
and executing the optimization algorithm embedded in the treatment planning system (TPS). The initial 
optimization constraint set will not generate the optimal plan, due to individual anatomy variations. 
Therefore, the planner is required to iteratively adjust the optimization objectives to make it clinically 
optimal. Due to the toxicity concerns of the GI structures and their proximity to the PTVs, planners 
usually rely on a trial-and-error approach and repetitively interact with the TPS to achieve clinical 
optimality. This process is time-consuming, and the resultant plan quality is highly subjective to planner 
experience. 
Reinforcement learning 5,6 presents a potential solution to this problem. A reinforcement learning 
agent—in our case, a planning bot—gains decision-making knowledge by repetitively interacting with the 
surrounding environment (TPS) and evaluating rewards (improvement of the plan dose distribution) 
associated with the action (changing of optimization objectives). State-action-reward-state-action 
(SARSA) 7, also known as connectionist Q-learning, is a widely-used reinforcement learning algorithm 
and has been proven to perform well in wide-ranging real-world applications such as controlling power 
systems 8, advanced robotics9, and playing video games 10,11. It is an efficient, sampling-based algorithm 
that sequentially changes the knowledge of the agent based on the interactive training process. We have 
developed a SARSA-based treatment planning bot that assists planners to efficiently achieve consistent 
and high-quality plans for pancreas SBRT treatments. We hypothesize that, through repetitive interactions 
with the TPS, the autonomous planning bot can learn to make appropriate adjustments given anatomical 
information and intermediate planning results, and ultimately design clinical optimal plans. 
 
2. Methods and Materials 
Pancreas SBRT treatment planning is a highly interactive process. Although the TPS can 
optimize plans with respect to the objective function given by the planner, the setting of planning 
objectives is highly dependent on the shape, size, and location of the PTVs. The planner usually interacts 
with the TPS multiple times and performs various actions including adjusting dose-volume constraints 
and creating necessary auxiliary structures in order to get desirable dose distributions. The action-making 
decisions are guided by the current planning status and the planner’s prior experience-based assessment. 
Here we adopt a SARSA reinforcement-learning framework to perform these tasks systematically. The 
formulation of SARSA is as follows 7: 
𝑄𝑄(𝑠𝑠,𝑎𝑎) ← 𝑄𝑄(𝑠𝑠,𝑎𝑎) + 𝛼𝛼 ∙ [𝑟𝑟(𝑠𝑠,𝑎𝑎, 𝑠𝑠′) + 𝛾𝛾 ∙ 𝑄𝑄(𝑠𝑠′,𝑎𝑎′) − 𝑄𝑄(𝑠𝑠, 𝑎𝑎)], 
where 𝑠𝑠 and 𝑎𝑎 denote the current state and action; 𝑠𝑠′ and 𝑎𝑎′ denote the next state and action; 𝑄𝑄 denotes 
the value function; r denotes the immediate reward; 𝛼𝛼 denotes the learning rate of the bot; and 𝛾𝛾 denotes 
the discount factor of the system. In particular, the action value function 𝑄𝑄 predicts the expected long-
term reward. The goal of the iteration during the training phase is to parameterize 𝑄𝑄, which can be 
subsequently used to guide future decision making. With linear function approximation, we formulate the 
action value function of the treatment planning RL problem as: 
𝑄𝑄𝜃𝜃(𝑠𝑠,𝑎𝑎) = 𝜃𝜃T𝜑𝜑(𝑠𝑠,𝑎𝑎), 
where 𝑄𝑄𝜃𝜃(𝑠𝑠,𝑎𝑎) represents the expected final score value at state s when action a is taken, 𝜃𝜃T denotes the 
feature vector that will be learned through the training process, and 𝜑𝜑(𝑠𝑠,𝑎𝑎) is a set of features carefully 
engineered to reduce the complexity of the reinforcement learning problem without losing out on 
generalization. In our implementation, the feature 𝜑𝜑(𝑠𝑠,𝑎𝑎) is generated as an outer product of a state 
vector 𝑓𝑓(𝑠𝑠) and an action vector 𝑔𝑔(𝑎𝑎): 𝜑𝜑(𝑠𝑠,𝑎𝑎) = 𝑣𝑣𝑣𝑣𝑣𝑣[ 𝑓𝑓(𝑠𝑠) ⨂ 𝑔𝑔(𝑎𝑎) ]. Here ⨂ denotes the outer product 
operator, which multiplies each element of the row vector 𝑓𝑓(𝑠𝑠) to each element of the column vector 
𝑔𝑔(𝑎𝑎). The state vector 𝑓𝑓(𝑠𝑠) is formulated as 𝑓𝑓(𝑠𝑠) = [△𝐷𝐷1,△𝐷𝐷2, … ,△𝐷𝐷𝑁𝑁], where △𝐷𝐷𝑛𝑛 = 𝐷𝐷𝑛𝑛 − 𝐷𝐷𝑛𝑛,𝑛𝑛 ∈[1,2,3, … ,𝑁𝑁] denotes the differences between the predicted/estimated dose constraints and the actual dose 
values at the current iteration. The complete state vector implemented for our pancreas SBRT planning 
module is listed in the supplementary materials.  
 
Table 1. Action options for the RL planning program.  
Action index Structure Volume Dose Priority Constraint 
type 
𝐴𝐴1, 𝐴𝐴2, 𝐴𝐴3 Primary PTV minus overlapping region 
with GI OARs with 0mm, 4mm, 6mm 
expansion 
96% D𝑝𝑝𝑝𝑝𝑝𝑝* 80 Lower 
𝐴𝐴4, 𝐴𝐴5, 𝐴𝐴6 Boost PTV minus overlapping region with  
GI OARs with 0mm, 4mm, 6mm expansion 
96% D𝑏𝑏𝑏𝑏𝑏𝑏* 80 Lower 
𝐴𝐴7, 𝐴𝐴8, 𝐴𝐴9 Bowel with 2mm, 4mm, 6mm expansion 0.5 cm
3 D 1𝑐𝑐𝑐𝑐 − 2 𝐺𝐺𝐺𝐺 80 Upper 
𝐴𝐴10, 𝐴𝐴11, 𝐴𝐴12 Duodenum with 2mm, 4mm, 6mm 
expansion 
0.5 cm3 D 1𝑐𝑐𝑐𝑐 − 2 𝐺𝐺𝐺𝐺 80 Upper 
𝐴𝐴13, 𝐴𝐴14, 𝐴𝐴15 Stomach with 2mm, 4mm, 6mm expansion 0.5 cm
3 D 1𝑐𝑐𝑐𝑐 − 2 𝐺𝐺𝐺𝐺 80 Upper 
𝐴𝐴16 PTVpri minus PTVbst 20 % D20% − 2 𝐺𝐺𝐺𝐺 50 Upper 
𝐴𝐴17 Liver  50 % 12 𝐺𝐺𝐺𝐺 50 Upper 
𝐴𝐴18 Kidneys 30 % 12 𝐺𝐺𝐺𝐺 50 Upper 
𝐴𝐴19 Cord 0 20 𝐺𝐺𝐺𝐺 50 Upper 
*D𝑝𝑝𝑝𝑝𝑝𝑝 and D𝑏𝑏𝑏𝑏𝑏𝑏 denote the prescription levels for the primary PTV and the boost PTV, respectively. 
The action vector 𝑔𝑔(𝑎𝑎) = [1(𝑎𝑎 = 𝐴𝐴1), 1(𝑎𝑎 = 𝐴𝐴2), … , 1(𝑎𝑎 = 𝐴𝐴𝑀𝑀)]T is an array of M indicators 
that represent indices of M actions. The M action options are designed based on the actions commonly 
taken by our clinical planners during pancreas SBRT treatment planning. Since we are taking sequential 
steps, the vector only has one non-zero component at any step during the iterations. In total, 19 actions are 
designed to ensure the bot has an optimal choice in any given state that may lead to the optimal plan 
quality. The actions include adding constraints to liver, kidney, cord, and auxiliary structures associated 
with stomach, duodenum, bowel, primary PTV, and boost PTV. Full descriptions of the actions are listed 
in Table 1. It is worth noting that the fixed priorities carried by the actions can be viewed as fixed step 
sizes. The bot takes one action per interaction and is allowed to take repeated actions.  
The reward r is assigned as the plan quality score improvement after each step: 𝑟𝑟 = 𝑆𝑆′ − 𝑆𝑆, where 
𝑆𝑆 and 𝑆𝑆′ denote the plan quality score before and after taking the current action, respectively. The plan 
score metric S is set as a weighted combination of various clinical plan quality metrics:   
𝑆𝑆 = −�𝑊𝑊𝑝𝑝𝑚𝑚𝑎𝑎𝑚𝑚(𝐾𝐾𝑝𝑝 − 𝐾𝐾𝚤𝚤� , 0)
𝑝𝑝
−�𝑊𝑊𝑗𝑗𝑚𝑚𝑎𝑎𝑚𝑚�𝐻𝐻𝑗𝑗 − 𝐻𝐻𝚥𝚥���, 0�2
𝑗𝑗
, 
where 𝐾𝐾𝚤𝚤� , 𝐻𝐻𝚥𝚥��� denote prescribed soft and hard constraints and 𝐾𝐾𝑝𝑝, 𝐻𝐻𝑗𝑗 denote achieved soft and hard 
constraint values. In this study, hard constraints refer to the constraints assigned to bowel, duodenum, 
stomach and cord. Soft constraints are the constraints for liver and kidney. The plan quality score S is re-
evaluated each time the bot takes one action. To keep the notation simple, we assign positive values to 
upper constraints (OAR sparing, PTV hotspot, dose conformity) and negative values to lower constraints 
(PTV coverage). The weights are selected carefully to reflect clinical plan quality preferences, which 
were consulted and reviewed with physician co-investigators during the experiment design. The current 
implementation focuses on getting as much target boost coverage as possible while satisfying GI structure 
D1cc dose constraints. This strategy is consistent with our current clinical practice preference, as the boost 
PTV prescription dose is likely to be higher for therapeutic gains. Different weightings of the plan quality 
scores produce planning bots with different tradeoff preferences, as the bot’s perception of expected long 
term rewards are directly linked to plan quality scores.  
Algorithm 1. Iteration scheme of the planning bot training phase 
Initialize the weighting vector 𝜃𝜃. 
Set exploration-exploitation factor ε, learning rate 𝛼𝛼, discount factor 𝛾𝛾. 
For Emax epochs 
      For M patients 
            Initialize plan, set initial constraints based on a template. Optimize plan. 
            Run N times 
                  Take action 𝑎𝑎 = 𝑎𝑎𝑟𝑟𝑔𝑔max
𝑎𝑎
𝑄𝑄𝜃𝜃(𝑠𝑠,𝑎𝑎) or a random action (ε-greedy). 
                  Optimize plan.  
                  Evaluate features 𝜑𝜑(𝑠𝑠′,𝑎𝑎′) and reward r. 
                  𝑄𝑄𝜃𝜃(𝑠𝑠′,𝑎𝑎′) =  𝜃𝜃𝑇𝑇𝜑𝜑(𝑠𝑠′,𝑎𝑎′) 
                  𝛿𝛿 = 𝑟𝑟 + 𝛾𝛾𝑄𝑄𝜃𝜃(𝑠𝑠′,𝑎𝑎′) − 𝑄𝑄𝜃𝜃(𝑠𝑠,𝑎𝑎) 
                  𝜃𝜃 ⟵ 𝜃𝜃 + 𝜂𝜂𝛿𝛿𝜑𝜑(𝑠𝑠,𝑎𝑎) 
 
The iteration scheme for the planning bot training process is given in Algorithm 1. During each 
iteration in the training process (Fig. 1a), a random number generator produces a number between 0 and 
1, and if the number is larger than the predetermined threshold ε, a random action is taken. Otherwise, 
optimal policy-based actions indicated by the current Q-function are taken. The introduced randomness in 
the training process allows the bot possibility to explore different/unseen actions and evaluate the values 
of these actions associated with the current state. This learning approach is known as ε-greedy. It allows 
the planning bot to explore the action-value space and acquire planning knowledge without being fully 
confined to prior experience. In this study, ε is set to gradually decrease over time: 
ε = 𝑚𝑚𝑎𝑎𝑚𝑚(0.05, 1 − 𝐸𝐸/𝐸𝐸𝑚𝑚𝑎𝑎𝑚𝑚), 
where 𝐸𝐸 and 𝐸𝐸𝑚𝑚𝑎𝑎𝑚𝑚 denote current epoch number and maximum epoch number, respectively. In each 
epoch, the planning bot practices planning once on each training case. The value of ε decreases linearly as 
the number of epochs increases and stays equal or greater to 0.05. It is worth noting that the randomness 
only exists in the training phase. In the validation phase, the planning bot only follows the guidance of the 
action-value function in every step.  
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Figure 1. The workflow of the proposed RL planning framework: (a) training phase (b) validation/application phase. 
 
The RL training and validation workflow, as shown in Fig. 1, has been implemented in a research 
TPS environment (EclipseTM Treatment Planning System Version 13.7, Varian Medical Systems, CA). 
Actions are defined as a set of function-calls inside the TPS during the planning phase, enabled by Eclipse 
Scripting Application Programing Interface (ESAPI). To evaluate the performance of the proposed 
planning bot framework, we anonymized and retrieved 40 biopsy-proven pancreatic cancer patients 
previously treated at our institution. Triphasic imaging technique was used during simulation for target 
delineation. The primary tumor and adjacent nodal disease were contoured on each imaging sequence. 
The union of these volumes was used as the internal target volume (ITV) because this volume should 
provide a good estimation of the tumor motion range during treatments. The boost PTV prescribed to 33 
Gy was defined as the GTV with a 2-3 mm margin and minus GI luminal structures. All 40 patients were 
treated with SIB technique to 25Gy/33Gy in 5 fractions. The OAR constraints of these patients were 
consistent with the multi-institutional phase II pancreas SBRT study by Herman et al12, in which the 
authors reported low rates of toxicity.  
In this dataset, 22 patients were planned on free-breathing CT, 5 patients were planned on 
average CT processed from free-breathing 4DCT sequences, and the remaining 13 patients were planned 
on breath-hold CT. The average sizes of primary PTVs (PTV25Gy) and boost PTVs (PTV33Gy) were 200 ± 
144 cm3 and 62 ± 32 cm3, respectively. The average volumes of liver and kidneys were 1504 ± 307 cm3 
and 320 ± 71 cm3.  From the cohort, 16 patients were randomly selected to train the RL planning bot. We 
augmented the training set to 48 plans by expanding the PTV33Gy by -2 mm, 0 mm, and 2 mm. The 
training workflow for a patient, as illustrated in Fig. 1a, consisted of N=15 sequential bot-TPS 
interactions. The RL system was trained with 20 epochs, meaning that the RL bot practiced planning by 
making 20 different plans for each of the 48 cases in the training set. For each plan, the planning bot 
initializes with a minimal set of optimization constraints, including PTV lower constraints, kidney, and 
liver upper constraints. The constraints are given to reduce the number of necessary bot-TPS interactions 
and accelerate the planning process. The only information carried over from an epoch to another was the 
weighting vector θ. After the RL bot was fully trained, following the workflow shown in Fig. 1b, we 
generated treatment plans for the remaining 24 patients and compared them with the clinical treatment 
plans.  
 
3. Results  
In order to determine the efficacy of using the proposed RL planning bot in the clinical 
environment, we validated the plan quality and examined the training process by analyzing the learning 
behavior of the planning bot, including state specificity of the bot during the training phase, knowledge 
interpretability, and knowledge reproducibility. 
3.1. Plan quality and efficiency 
It took 5 days to train an RL bot on a single Varian workstation. For the validation set, the bot 
spent 7.3 ± 1.0 min on each case to create a deliverable plan from a set of contours. This is a significant 
improvement over manual planning, which typically takes 1-2 hours. Figure 2 shows the planning results 
for cases in the validation set. All OAR constraints have been met by both clinical plans and RL bot 
plans. All 24 clinical plans and 24 RL plans meet pre-defined GI constraints (V33Gy<1cc). PTV 
coverages are comparable between RL plans (PTV25Gy: 98.5 ± 1.4 %, PTV33Gy: 94.6 ± 4.8 %) and clinical 
plans (PTV25Gy: 99.8 ± 0.2 %, PTV33Gy: 94.7 ± 1.2 %). We observe smaller PTV coverage variations on 
the bot plans because the score function does not reward coverages beyond 95% coverage. [13] The mean 
MU value of the bot plans is higher (1995 ± 351 MU) than that of clinical plans (1742 ± 271 MU), 
indicating the complexity of the bot plan is slightly higher than that of the clinical plans. 
 
Figure 2. Dosimetric comparison between RL bot plans and clinical plans. The boxes represent quartiles, and the whiskers 
mark the datapoints within the 1.5 interquartile ranges (IQR) from the median values. The clinical constraints for bowel D1cc, 
duodenum D1cc, stomach D1cc are 33 Gy. Cord Dmax is limited below 20 Gy, and kidney V12Gy is limited below 25%-50%. All 
clinical plans and RL bot plans meet these clinical constraints.      
 
Figure 3 shows dose distributions of two randomly selected validation plans (Fig. 3d-3f, Fig. 3j-
3l) and their corresponding clinical plans (Fig. 3a-3c, Fig. 3g-3i). The RL-plans show similar PTV 
coverages compared to the clinical plans. However, the RL plans tend to exhibit better conformity on 33 
Gy isodose lines but tend to over cover PTV25Gy. This is likely due to the fact that the score function S 
does not explicitly penalize dose spill out of the primary PTV into non-OAR regions. 
 
 
 
 
 
 
 
 
 
 
 
 
    
    
    
Figure 3. Cross-sections of two randomly selected clinical plans: (a-c) (g-i) and the corresponding RL plans (d-f) (j-l) . The 
three rows, from top to bottom, are axial, coronal, and sagittal views, respectively. The prescription doses to the primary PTV 
(red segments) and the boost PTV (magenta segments) are 25 Gy and 33 Gy, respectively. The 25 Gy and 33Gy isodose lines 
are represented by cyan and yellow lines. The dose limit to GI luminal structures (light green contours) is 33Gy less than 1cc. 
 
3.2. Knowledge interpretability 
 The feature weighting factors 𝜃𝜃T contains information regarding the expected plan quality 
change, measured by the plan quality score function S, after a certain action at a certain state. An action is 
usually considered optimal when the feature value vector is well aligned with the corresponding row on 
𝜃𝜃T. This characteristic of the model makes the model readily interpretable. Figure 4 shows two regions of 
the reshaped 𝜃𝜃T. The full feature map is shown in the supplementary material document. 
Figure 4a illustrates that the bot has learned that when both PTV33Gy coverage and stomach D1cc 
constraints are compromised, it should consider adding lower constraint to an auxiliary structure that 
avoids the overlapping region between the PTV and the stomach. In contrast, it is often not effective to 
directly add PTV lower constraints. Similarly, Fig. 4b shows that adding stomach+6mm upper constraints 
is preferred when PTV33Gy D98% is slightly violated and the stomach D1cc dose constraint is violated. Such 
learned knowledge is consistent with our planning experience. Therefore, we conclude that the RL bot 
learns to make sensible choices given the state information and our formulation of the action-value 
function offers meaningful insights into the learned planning strategies in the form of a “knowledge map”. 
The RL learning provides a systematic and subjective methodology of learning planning knowledge. 
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3.3. Knowledge reproducibility 
Our experiments have also demonstrated that the training of the RL bot is highly reproducible. 
Figure 5 shows the average differences of feature weighting factors 𝜃𝜃𝑇𝑇 learned in two separate training 
sessions. The average absolute change is 2.5%. Considering that the training sessions involve substantial 
introduced stochasticity, the differences between the two knowledge maps are relatively small, which 
preliminarily shows that the model training procedure is reproducible. 
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Figure 5. Average knowledge map differences across (a) different features and (b) different 
actions. 
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 Figure 4. The weighting vector 𝜃𝜃Treshaped based on features and actions corresponding to: (a) PTV coverage 
and (b) stomach constraints. The weightings are of arbitrary units. At each bot-TPS interaction, we get action-
value 𝑄𝑄(𝑠𝑠, 𝑎𝑎) by multiplying  𝜃𝜃T by the feature vector 𝜑𝜑(𝑠𝑠,𝑎𝑎), which is evaluated in the TPS at the step. 
  
4. Discussion 
In pancreas SBRT treatment planning, GI structures (small bowel including duodenum, large 
bowel and stomach) are often the structures limiting full boost PTV coverage, due to its proximity to the 
boost PTV. Planners iteratively evaluate the quality of boost PTV dose coverage with respect to the GI 
constraints and make adjustments accordingly. Notably, several actions are often taken when a planner 
modifies a plan, including adjusting priority or placement of existing structures and adding auxiliary 
structures to guide the local/regional dose dispositions, in both volume size and dose levels. We have 
formulated this process into a finite-horizon reinforcement-learning framework, the crucial components of 
which include states, actions, and rewards. First, we have discretized the states, in a similar fashion to 
how planners evaluate plans (i.e. constraint satisfaction). Second, we have identified a set of common 
actions that planners would take to address different planning issues, such as insufficient coverage, dose 
spill, etc. Third, we have derived a reward system based on our physicians’ input. Finally, we have 
managed to limit the complexity of the system and thereby created a planning bot that can be 
implemented in a clinical TPS. 
The training stage of the planning bot essentially simulates the learning process of a human 
planner. The bot first takes many attempts in trying different actions at different states, and after each 
action, the plan is re-evaluated, and a reward is assigned accordingly. As the bot gains planning 
experience gradually, it makes decisions with the guidance of retained prior knowledge, but also makes 
attempts to explore the alternative methods for surprise gains. After completing the training process, the 
bot has acquired knowledge that can guide it to get the highest plan quality possible. The knowledge, 
summarized in an action value function, contains the information of expected long-term rewards of taking 
certain actions at certain states. When planning a new patient case, the bot periodically evaluates the 
current state of the plan, infers the best option from the action value function, and takes the corresponding 
action, thus completing the navigation of autonomous planning process. To fully utilize the geometrical 
information contained in the training dataset, we have augmented the training dataset by expanding and 
shrinking the boost PTVs. This step effectively allows the bot to practice planning on sufficient 
anatomical variations without requiring more training cases. We have introduced variations on the boost 
PTV because the primary focus of the planning bot is to effectively handle the contradicting boost PTV 
coverage requirements and GI OAR 1cc constraints. Similar augmentation methods can potentially be 
applied to increase the variations on other OARs. During the development of the planning bot, we tuned 
the RL model by using the plan quality scores of a few hold-out training cases to gauge the performance 
of the bot. Specifically, we have determined the number of actions necessary and the number of cases 
required for model training, in addition to the model parameters such as ε and N. We have estimated that 
more than 10-20 cases are necessary to train the bot, though the number of cases needed is dependent on 
the degree of anatomy variations for the treatment site and the requirements of the planning task.   
The limitations of this model are twofold. First, the linear approximation used in this work, while 
interpretable, potentially limits the flexibility of the model when approximating the underlying action 
values, i.e. the ground truth of the expected long-term reward, for more complicated planning tasks. In 
this study, we used a SARSA algorithm with linear action value function approximation to determine 
optimal actions. It may be necessary to investigate the use of other types of value function classes, such as 
deep neural networks 11. However, a more complicated model is expected to have less interpretability and 
require more tuning, both of which are undesirable for clinical applications. Another potential limitation 
of the proposed method is that the actions have to be discretized to fit in the SARSA framework. This is 
reflected in the fact that we have set the planning constraint priorities to be constant. The priorities were 
selected carefully such that placing a constraint introduces sufficient plan changes and yet does not 
overshoot. With policy gradient-based RL algorithms, it is possible to learn the optimal policy directly in 
a continuous domain. This class of algorithms is also worth investigating for performing treatment 
planning tasks. In this study, we have applied the RL planning bot to solving a challenging planning task 
known to be heavily reliant on planner input. However, the RL bot is not limited to this specific treatment 
planning task. The model can be adopted for other treatment sites by using a different set of features and 
actions to match the planning practices. In addition, the plan quality score should be re-defined to reflect 
the clinical plan quality preferences.  
Previously, automated planning based on supervised machine learning has gained widespread 
acceptance in the radiation therapy community13-16 and has been implemented in commercial TPS17. This 
class of algorithms, collectively referred to as knowledge-based planning (KBP), train a model to 
represent the correlation between patient anatomy and dose distribution based on previously treated 
patients. For a new patient, KBP predicts the best achievable OAR DVHs and generates corresponding 
dose-volume constraints as input for plan optimization. Compared with KBP, the RL bot is different in 
two aspects. Firstly, the bot does not rely on optimal plans in training data. The underlying assumption of 
KBP is that the plans used for model training are optimal under the current standard. In contrast, the RL 
bot acquires planning knowledge by trial-and-error and thereby does not require previous plans. As a 
result, when a planning protocol gets updated, the planning bot can be simply re-trained with updated 
score function while KBP cannot be used until enough new plans have been collected and the model can 
be re-trained. Secondly and more importantly, KBP places a set of estimated dose-volume constraints for 
optimization. This method, while performing well for many treatment sites, is not sufficient to address the 
complex local tradeoffs in pancreas SBRT. The lack of spatial information in dose-volume constraints 
results in inefficient cost function assignment and the planner often needs to create local optimization 
structures to encode the spatial information manually, which is time-consuming and defeats the purpose 
of auto-planning.  
To our knowledge, there have been very few publications applying reinforcement learning to 
external beam treatment planning tasks, and this is the first work on implementing RL planning in a 
clinical TPS. Shen el al. has recently proposed a deep reinforcement learning-based prostate IMRT virtual 
planner, which utilizes neural networks to adjust dose-volume constraints 18. They have shown that the 
virtual planner improves plan quality upon the initialized plans and is a potentially promising planning 
method, acknowledging that the method can be a “black box”. In contrast, we have made significant 
efforts to simplify the model to improve transparency and demonstrate the efficacy of an autonomous, yet 
interpretable planning bot powered by reinforcement learning. We narrowed down features to a limited 
set of variables summarized from domain knowledge, namely those commonly used by our planners to 
examine the treatment plans before implementing manual plan changes. Also, we used linear function 
approximation for the action value determination, which presents a simple and interpretable model. In this 
study, we have focused on the planning of pancreas SBRT treatments. However, the proposed framework 
should apply to other treatment sites with careful design of features and actions.  
5. Conclusion 
The planning bot generates clinically acceptable plans by taking consistent and predictable 
actions. Additionally, the knowledge maps learned in separate training sessions are consistent, and the 
knowledge learned by the RL bot is consistent with human planning knowledge. Therefore, the training 
phase of our planning bot is tractable and reproducible, and the knowledge obtained by the bot is 
interpretable. As a result, the trained planning bot can be validated by human planners and serve as a 
robust planning assistance routine in the clinics. 
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